Biotechnology Assets, S.A. (BST:041)

Germany flag Germany · Delayed Price · Currency is EUR
0.2160
-0.0030 (-1.37%)
At close: Feb 26, 2026
Market Cap15.97M -29.4%
Revenue (ttm)3.05M -9.5%
Net Income-2.08M
EPSn/a
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.2220
Previous Close0.2190
Day's Range0.2070 - 0.2220
52-Week Range0.1130 - 0.5240
Betan/a
RSI58.66
Earnings DateApr 7, 2026

About Biotechnology Assets

Biotechnology Assets, S.A. develops and markets biotechnological assets for applications in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a protein engineering tool that allows the conjugation of proteins through the formation of new peptide bonds; universal switchable split-chimeric antigen receptor (CAR); VACC-ZERA technology, a tool to generate recombinant proteins in microparticles suited for therapeutic and prophylactic adjuvant free vaccines administer... [Read more]

Industry Pharmaceutical Preparations
CEO Jaime Feced Rubio
Employees 30
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol 041
Full Company Profile

Financial Performance

Financial Statements